Fatro S.p.A – Healthcare & Services
In January, the investment in Fatro S.p.A. (“Fatro”) completed. Fatro is a family-owned Italian company specialising in the veterinary pharmaceutical sector, producing medicines and vaccines linked to animal health and well-being.
Company overview
Core Mid-Market
HQ Location: Italy
Sector: Healthcare & Services
Investment rationale
Fatro is strong in the animal health sector with an international presence, serving customers in over 90 countries and operating through subsidiaries in key markets including Turkey, Spain, Greece, Argentina and India. The investment aims to further strengthen Fatro’s market share while accelerating international growth, supported by Investindustrial’s track record of partnering with high‑quality, family‑owned companies.
Value creation
Fatro offers clear opportunities to further enhance scale and profitability. The value creation plan focuses on accelerating international expansion, strengthening commercial excellence, expanding higher‑margin product categories and supporting innovation across the product pipeline, while continuing to invest in manufacturing and quality capabilities.
Strategic positioning
Fatro offers clear opportunities to further enhance scale and profitability. The value creation plan focuses on accelerating international expansion, strengthening commercial excellence, expanding higher‑margin product categories and supporting innovation across the product pipeline, while continuing to invest in manufacturing and quality capabilities.
